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Introduction
Small bowel transplantation is a curative procedure for the
treatment of irreversible intestinal failure with the compli-
cations of parenteral nutrition or for extensive intra-
abdominal disease requiring evisceration. 26 isolated small
bowel transplants were performed in the UK in 2014 [1].
With advances in surgical techniques and the evolution of
immunosuppressants, notably monoclonal antibody ther-
apy, small bowel transplantation is increasingly considered
feasible in many patients with intestinal failure.
Objectives
To study the outcomes of small bowel transplants in our
hospital and compare 90-day and 1-year mortality rates
with the UK Transplant Registry Data and the US Scienti-
fic Registry of Transplant Recipients.
Method
A review of all isolated small bowel transplants undertaken
at the Churchill Hospital between October 2008 and July
2014. The medical notes and computer databases of the
28 patients were reviewed retrospectively and data
extracted on patient demographics, indications for trans-
plantation and outcomes. The primary outcomes were
90-day and 1-year mortality. Other outcomes recorded
include length of ICU stay, length of hospital stay and ICU
readmissions rates. A Kaplan Meier curve was constructed
to analyse mortality.
Results
The mean age was 41.5 ± 12.8 years and 57% were male.
Inflammatory bowel disease (32.1%) and malignancy
(21.4%) were the commonest indications for transplanta-
tion. Other indications were myopathies, radiation enteri-
tis and ischaemic bowel. The 90-day mortality was 89.3%
and 1-year mortality was 80.8%, with a mean survival time
of 1413 ± 368 days. The mean post-operative length of
stay on ICU was 7.2 ± 9.7 days. The mean overall ICU
length of stay was 14.4 ± 16.5 days with a readmission rate
of 44.8%. 85% of these patients were re-admitted more
than once, from 10 to 1948 days following initial ICU
discharge post-operatively.
Conclusions
Our 90-day and 1-year mortality rates compare favourably
with the UK Transplant Registry Outcomes [1], which has
90-day and 1-year mortality rates of 87% and 80% respec-
tively and with the US Scientific Registry of Transplant
Recipients Annual Data Report of 2013 [2]. The critical
care input for these patients often extends beyond the
initial post-operative period, as our data demonstrates.
The 2012 SRTR report found that 86% of recipients were
rehospitalised within 6 months of transplant [3]. Sepsis
and rejection are common complications, which when
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Figure 1 Small Bowel Transplant Survival.
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accompanied by difficult vascular access can make the
management of transplant patients challenging and
resource intensive.
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